GCI Seminar Series November 2023: Long-term EEG monitoring using the Minder system
Share via
Presenter: John Heasman
Date and Time: 12.30pm - 1.30pm, Wednesday 15 November 2023
Venue: Theatre 2 (Basement 1), 207 – 221 Bouverie St (BLD 379) Or via Zoom link (https://unimelb.zoom.us/j/84881831900?pwd=M1FqNElrNzJKYmJSS25KcSs0Wm50Zz09&from=addon Passcode: 575902)
Light refreshment is provided at the end of the seminar for in-person attendees.
ABSTRACT:
Australian medical device innovator Epi-Minder Pty Ltd has received FDA Breakthrough Device Designation for its ultra-long term epilepsy monitor known as Minder®. The Minder device is under clinical evaluation. It is a novel sub-scalp EEG monitoring technology and has the potential to transform the way epilepsy is managed and treated. Through continuous monitoring of EEG over months to years, Minder has the potential to provide more accurate seizure detection than current standard of care.
ABOUT THE PRESENTER:
John has over 20 years’ experience in medical devices. He provides specialist expertise, operations management and leadership for global activities and teams. John joined Epiminder as the COO in 2020.